Tailored patient values elicitation task for rectal cancer treatment decision-making

Tailored patient values elicitation task for rectal cancer treatment decision-making - ABEL

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON39040

Enrollment

174

Registered

2010-07-29

Start date

2011-01-01

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rectal cancer

Interventions

The intervention group will be asked to complete the ACA-task immediately prior to their visit to the radiation oncologist, in the waiting area of the radiotherapy department. It is expected that ti

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: patient newly diagnosed with primary rectal cancer; advised to undergo 5x5Gy pre-operative radiotherapy; tumorstage T2N0-1M0 or T3N0-1M0, located 5-15 cm from the anal verge; scheduled to undergo a low anterior resection (without permanent stoma); and with adequate mastery of the Dutch language in speech and writing

Exclusion criteria

Exclusion criteria: Distal metastases

Design outcomes

Primary

Measure	Time frame
The proposed research aims to carry this research further, to evaluate patient and radiation oncologists* acceptance of an ACA-task incorporated as part of routine primary rectal cancer care, and to evaluate its effectiveness on: 1) the extent to which patients* values regarding treatment outcomes and tradeoffs underlying the PRT decision are explicitly communicated during the visit to the radiation oncologist; 2) correspondence between treatment choice and patient values for late side effects; 3) patients* ability to cope with late side effects at one-year follow-up.	—

Measure

Time frame

The proposed research aims to carry this research further, to evaluate patient and radiation oncologists* acceptance of an ACA-task incorporated as part of routine primary rectal cancer care, and to evaluate its effectiveness on: 1) the extent to which patients* values regarding treatment outcomes and tradeoffs underlying the PRT decision are explicitly communicated during the visit to the radiation oncologist; 2) correspondence between treatment choice and patient values for late side effects; 3) patients* ability to cope with late side effects at one-year follow-up.

—

Secondary

Measure	Time frame
n.a.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)